ARCHIVES

ODAC Unanimously Rejects Melblez, Citing Lower Survival

This article is from The Cancer Letter archive.

Vol. 39 No. 20 | May 17, 2013

Download PDF Visit The Full Archive

Related Articles

Group Opposes Bill To Allow Drug Sales After Phase I.

May 26, 2006

ACS Board Tables Proposal For Accepting State, Local Funds

December 3, 1993

New Structure Of Divisions Outlined

September 15, 1995

Give Young Women Data, Not Guidelines, Advisors Tell NCI; consensus For Over 50

October 29, 1993

Bush Appoints Andrew von Eschenback, Of M. D. Anderson, As 12th NCI Director.

December 7, 2001

Shuttle Vector Technology Concept Approved

February 28, 1986